146 related articles for article (PubMed ID: 21483015)
1. Long-term complications of lymphoma and its treatment.
Ng AK; LaCasce A; Travis LB
J Clin Oncol; 2011 May; 29(14):1885-92. PubMed ID: 21483015
[TBL] [Abstract][Full Text] [Related]
2. Late effects of Hodgkin's disease and its treatment.
Ng AK; Mauch PM
Cancer J; 2009; 15(2):164-8. PubMed ID: 19390314
[TBL] [Abstract][Full Text] [Related]
3. Late complications of therapy of Hodgkin's disease: prevention and management.
Ng AK; Mauch PM
Curr Hematol Rep; 2004 Jan; 3(1):27-33. PubMed ID: 14695846
[TBL] [Abstract][Full Text] [Related]
4. Are we improving the long-term burden of Hodgkin's lymphoma patients with modern treatment?
Aleman BM; van Leeuwen FE
Hematol Oncol Clin North Am; 2007 Oct; 21(5):961-75. PubMed ID: 17908631
[TBL] [Abstract][Full Text] [Related]
5. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
6. Review of the cardiac long-term effects of therapy for Hodgkin lymphoma.
Ng AK
Br J Haematol; 2011 Jul; 154(1):23-31. PubMed ID: 21539537
[TBL] [Abstract][Full Text] [Related]
7. Adult survivors of childhood malignant lymphoma are not aware of their risk of late effects.
Hess SL; Jóhannsdóttir IM; Hamre H; Kiserud CE; Loge JH; Fosså SD
Acta Oncol; 2011 Jun; 50(5):653-9. PubMed ID: 21261507
[TBL] [Abstract][Full Text] [Related]
8. Impact of treatment-related cardiac toxicity on lymphoma survivors: an institutional approach for risk reduction and management.
Walsh MC
Clin J Oncol Nurs; 2010 Aug; 14(4):505-7. PubMed ID: 20682507
[TBL] [Abstract][Full Text] [Related]
9. Second cancers in survivors of hodgkin lymphoma: risks and recommendations.
Leahy Y
Clin J Oncol Nurs; 2008 Jun; 12(3):437-42. PubMed ID: 18515242
[TBL] [Abstract][Full Text] [Related]
10. Secondary lung tumors in hematological patients.
Amadori D; Ronconi S
Semin Respir Crit Care Med; 2005 Oct; 26(5):520-6. PubMed ID: 16267703
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
[TBL] [Abstract][Full Text] [Related]
12. [Long-term complications following treatment of testicular cancer and Hodgkin lymphoma].
van den Belt-Dusebout AW; Aleman BM; Gietema JA; de Wit R; van 't Veer MB; Lugtenburg PJ; Krol AD; van Leeuwen FE
Ned Tijdschr Geneeskd; 2010; 154(45):A2229. PubMed ID: 21118593
[TBL] [Abstract][Full Text] [Related]
13. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
15. Long-term mortality from second malignant neoplasms in 5-year survivors of solid childhood tumors: temporal pattern of risk according to type of treatment.
Tukenova M; Diallo I; Hawkins M; Guibout C; Quiniou E; Pacquement H; Dhermain F; Shamsaldin A; Oberlin O; de Vathaire F
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):707-15. PubMed ID: 20200431
[TBL] [Abstract][Full Text] [Related]
16. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
17. Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma.
Kong LR; Huang CF; Hakimian D; Variakojis D; Klein L; Kuzel TM; Gordon LI; Zanzig C; Wollins E; Tallman MS
Cancer; 1998 Mar; 82(5):957-64. PubMed ID: 9486587
[TBL] [Abstract][Full Text] [Related]
18. The cohort of long-term survivors at the German childhood cancer registry.
Debling D; Spix C; Blettner M; Michaelis J; Kaatsch P
Klin Padiatr; 2008; 220(6):371-7. PubMed ID: 18949673
[TBL] [Abstract][Full Text] [Related]
19. Survivorship: adult cancer survivors.
Ganz PA
Prim Care; 2009 Dec; 36(4):721-41. PubMed ID: 19913184
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
